Director, Quality Assurance, Japan

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Revolution Medicines is seeking a Quality Assurance professional to serve as Quality Assurance (Hinseki) for its Japan entity. This role has a primary focus on quality management and quality oversight, including quality systems, manufacturing and supply chain quality, and CMC-related quality activities. In addition, the position will serve as the Quality Assurance (Hinseki) as defined under the Japanese GQP Ordinance, supporting the establishment and maintenance of the Japan Marketing Authorization Holder (MAH). The position also works closely with Marketing Supervisor General (Soseki) and Safety Manager (Anseki) as part of the legally required three-role framework, ensuring effective governance, communication, and decision-making across quality and safety domains. Key Responsibilities： Lead quality management and quality oversight activities for the Japan entity, including the design, implementation, and maintenance of quality systems appropriate for a pre-commercial and early-stage organization. Ensure integration of Japan specific requirements into global quality management systems (QMS). Provide quality oversight for manufacturing, testing, CMC, and supply chain activities, ensuring compliance with applicable Japanese GMP/GQP/GDP requirements Assess and manage quality risks related to manufacturing processes, materials, testing, deviations, changes, and supply continuity. Serve as the designated Quality Assurance Manager (Hinseki) under the GQP Ministerial Ordinance, establishing required quality standards, procedures, and quality agreements for MAH operations. Establish and oversee market release decision processes and quality governance frameworks appropriate for the company’s development stage. Collaborate closely with Marketing Supervisor General (Soseki) and Safety Manager (Anseki) to ensure alignment across quality, safety, and regulatory responsibilities. Establish clear communication and escalation pathways among the three roles to support compliant and timely decision-making. Act as the primary quality contact with PMDA and prefectural authorities, as applicable, particularly during MAH establishment and inspections. Partner with Global Quality, CMC, Supply Chain, and Regulatory teams to ensure alignment between global standards and Japan regulatory expectations. Lead GMP-related quality oversight for both domestic and foreign manufacturing sites supplying products for the Japan MAH. Support registration, accreditation, and ongoing compliance of domestic and foreign manufacturing sites from a quality and GMP perspective, including initial applications, maintenance, and changes. Lead preparation for PMDA inspections, partner audits and global internal audits. Serve as the QA lead duing regulatiory inspections, including taking appropriate corrective and preventative actions (CAPA) to audit observations and responding to authorities in a timely manner. Oversee quality agreements with CMO’s, distributors and testing laborartories ensuring compliance with Japanese regulations. Review and assess GMP- and quality-related documentation for manufacturing site registration, changes, and inspections, in collaboration with Regulatory Affairs, Global Quality, and